Document Migration

PRODUCTS

  • Streamline your Trial Master File (TMF) documentation and integrate with study sites to accelerate trial timelines.

    Other eTMFs promise ease of use and seamless integration with the sites eISF, but they can’t deliver 100% adoption.

  • Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

  • Eurofins PSS Insourcing Solutions® (PSS) is a global, award-winning managed service provider that places our people at your site dedicated to running and managing your manufacturing and laboratory services while eliminating headcount, co-employment and project-management worries.

  • IntegriCell™ cryopreservation services from Cryoport Systems optimize leukapheresis-derived cell therapies by enhancing the safety, quality, and viability of manufacture-ready cryopreserved leukopaks. Our state-of-the-art cryopreservation process, integrated with our end-to-end global temperature-controlled supply chain platform, provides unmatched reliability, efficiency, and scope. Our standardized protocols meet the highest compliance standards, ensuring consistent quality and addressing product stability issues associated with fresh donor-derived cellular material for an optimized approach that enhances manufacturing efficiency and streamlines operations.

  • HighByte Intelligence Hub is a DataOps software solution purpose-built for industrial data. The Intelligence Hub enables manufacturers to securely connect, model, condition, and flow valuable industrial data to and from IT systems without writing or maintaining code. The software is deployed at the Edge to merge real-time, transactional, and time-series data into a single payload for consuming applications.

    With the Intelligence Hub, users can speed system integration time, rapidly leverage contextualized data for analytics, AI, and ML applications, and govern data standards across the enterprise. HighByte Intelligence Hub provides the critical data infrastructure for Pharma 4.0.

WHITE PAPERS AND CASE STUDIES

NEWS